Senior Field Reimbursement Manager - HIV Prevention - Dallas, TX
Gilead Sciences
Summary
The Senior Field Reimbursement Manager – HIV Prevention is a highly specialized, priority account-focused role responsible for supporting access and reimbursement optimization across large, complex health systems, IDNs, and national or regional accounts that span multiple geographies and require additional coordination and access/reimbursement support. The remote/field-based role supports strategic, multi-location, multi-state, multi-region or national Priority/SWAT accounts. Candidates must reside in or near the assigned geography and be able to travel extensively to engage account stakeholders in person.
Job description
Key Responsibilities
- Develop and manage strategic business relationships with key account stakeholders across large health systems, IDNs, specialty pharmacies, national/regional accounts, and Priority/SWAT accounts to facilitate patient access to Gilead’s HIV Prevention products.
- Serve as an enterprise-level reimbursement and access expert, using influence mapping to identify executive, pharmacy, billing, implementation, provider, and operational stakeholders across complex organizations.
- Lead coordinated, cross-regional account strategies that reduce duplication of effort, improve role clarity across local FRMs and matrix partners, and enable consistent customer support across multi-site accounts.
- Assess systemic access and reimbursement barriers impacting multiple sites, including benefit verification, prior authorization, medical exception, claims, acquisition, specialty pharmacy, and LAI operational workflows.
- Partner with senior account stakeholders and internal matrix teams to establish, optimize, and support scalable reimbursement processes aligned to the account’s operating model.
- Provide information and support to the internal patient support program team in enhancing HUB and FRM processes, including education on prior authorizations, benefit verification, case management handoffs, and account-specific workflow optimization.
- Communicate changes in formulary, coverage, payer policy, or reimbursement processes for Gilead products and ensure strategic accounts receive timely education and support on requirements such as prior authorization and medical exception pathways.
- Create and deploy instructional resources, account implementation plans, and best-practice education that help providers, office staff, billing teams, revenue cycle teams, and implementation stakeholders understand reimbursement processes at scale.
- Increase appropriate coordination between FRMs, Long-Acting Implementation Directors, Strategic Account Managers, Prevention Specialists, Market Access, the Gilead HUB, Marketing, Patient Support, and other cross-functional partners to improve communication channels and account execution.
- Identify bottlenecks in the patient journey that hinder initial or ongoing access and use appropriate technology tools, insights, and escalation pathways to respond to high-need account situations.
- Measure success through education delivery, implementation success, systemic issue/process resolution, improved coordination, and scalable access/reimbursement support across strategic accounts.
Cultural Sensitivity
Demonstrates open-mindedness and flexibility, being aware of cultural similarities and differences without assigning value and adapts support to varying account environments and practices without being overly prescriptive.
Patient-Centric Focus
Embodies a collaborative approach wholly dedicated to ensuring patient access and positive outcomes through teamwork, placing patient and team success at the forefront.
Requirements
- Bachelor's Degree and Eight Years' Experience OR Masters' Degree and Six Years' Experience OR Ph.D.
- BA/BS/RN with 8+ years of experience working for a major pharmaceutical organization on a field reimbursement, access, patient services, market access, account management, or related team
- MA/MS/PharmD with 6+ years of experience working for a major pharmaceutical organization in field reimbursement, access, patient services, market access, account management, or related role
- Prior leadership, enterprise account, IDN/health system, or cross-functional account strategy experience is strongly preferred
- Deep understanding of the relationship between payers, providers, health systems, specialty pharmacies, and pharmaceutical companies in reimbursement and access
- Demonstrated experience engaging with and managing large, complex provider accounts, multi-location health systems, IDNs, national/regional accounts, and/or accounts spanning multiple states or regions
- Familiarity with pharmacy benefits, medical benefits, specialty payer landscape, reimbursement pathways, and acquisition models across commercial, Medicare, Medicaid, and other payer segments
- Understanding of local, state, and national policy changes and their effect on reimbursement, coverage, acquisition, and account workflows
- Experience partnering with specialty pharmacies and HUB services to support account-specific workflow optimization and patient access processes
- Ability to influence without authority, align matrixed stakeholders, and translate account-level barriers into scalable process improvements
- Strong executive presence and comfort engaging C-suite or executive leadership, pharmacy directors, revenue cycle leaders, implementation leaders, and system stakeholders
- A willingness to travel 75% of the time across designated regions and strategic accounts
- Candidates must reside in or near the assigned geography
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Discretionary Annual Bonus
- Stock-Based Long-Term Incentives
- Paid Time Off
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.